Literature DB >> 32108696

Assessment of Lesion Detectability in Dynamic Whole-Body PET Imaging Using Compartmental and Patlak Parametric Mapping.

Neda Zaker, Fotis Kotasidis1, Valentina Garibotto1, Habib Zaidi.   

Abstract

PURPOSE: Hybrid dynamic imaging allows not only the estimation of whole-body (WB) macroparametric maps but also the estimation of microparameters in the initial bed position targeting the blood pool region containing the pathology owing to the limited axial field of view of PET scanners. In this work, we assessed the capability of multipass WB F-FDG PET parametric imaging in terms of lesion detectability through qualitative and quantitative evaluation of simulation and clinical studies.
METHODS: Simulation studies were conducted by generating data incorporating 3 liver and 3 lung lesions produced by 3 noise levels and 20 noise realizations for each noise level to estimate bias and lesion detection features. The total scan time for the clinical studies of 8 patients addressed for lung and liver lesions staging, including dynamic and static WB imaging, lasted 80 minutes. An in-house-developed MATLAB code was utilized to derive the microparametric and macroparametric maps. We compared lesion detectability and different image-derived PET metrics including the SUVs, Patlak-derived influx rate constant (Ki) and distribution volume (V) and K1, k2, k3, blood volume (bv) microparameters, and Ki estimated using the generalized linear least square approach.
RESULTS: In total, 104 lesions were detected, among which 47 were located in the targeted blood pool bed position where all quantitative parameters were calculated, thus enabling comparative analysis across all parameters. The evaluation encompassed visual interpretation performed by an expert nuclear medicine specialist and quantitative analysis. High correlation coefficients were observed between SUVmax and Kimax derived from the generalized linear least square approach, as well as Ki generated by Patlak graphical analysis. Moreover, 3 contrast-enhanced CT-proven malignant lesions located in the liver and a biopsy-proven malignant liver lesion not visible on static SUV images and Patlak maps were clearly pinpointed on K1 and k2 maps.
CONCLUSIONS: Our results demonstrate that full compartmental modeling for the region containing the pathology has the potential of providing complementary information and, in some cases, more accurate diagnosis than conventional static SUV imaging, favorably comparing to Patlak graphical analysis.

Entities:  

Mesh:

Year:  2020        PMID: 32108696     DOI: 10.1097/RLU.0000000000002954

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  5 in total

1.  Early Diagnosis of Murine Sepsis-Associated Encephalopathy Using Dynamic PET/CT Imaging and Multiparametric MRI.

Authors:  Tianxing Zhu; Jiayi Jiang; Yitai Xiao; Duo Xu; Zibin Liang; Lei Bi; Min Yang; Mingzhu Liang; Dan Li; Yong Lin
Journal:  Mol Imaging Biol       Date:  2022-05-25       Impact factor: 3.488

2.  Improved Clinical Workflow for Whole-Body Patlak Parametric Imaging Using Two Short Dynamic Acquisitions.

Authors:  Hui Wang; Ying Miao; Wenjing Yu; Gan Zhu; Tao Wu; Xuefeng Zhao; Guangjie Yuan; Biao Li; Huiqin Xu
Journal:  Front Oncol       Date:  2022-04-28       Impact factor: 5.738

3.  Clinical validation of a population-based input function for 20-min dynamic whole-body 18F-FDG multiparametric PET imaging.

Authors:  André H Dias; Anne M Smith; Vijay Shah; David Pigg; Lars C Gormsen; Ole L Munk
Journal:  EJNMMI Phys       Date:  2022-09-08

4.  Direct inference of Patlak parametric images in whole-body PET/CT imaging using convolutional neural networks.

Authors:  Neda Zaker; Kamal Haddad; Reza Faghihi; Hossein Arabi; Habib Zaidi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-06-18       Impact factor: 10.057

5.  Whole-body voxel-based internal dosimetry using deep learning.

Authors:  Azadeh Akhavanallaf; Iscaac Shiri; Hossein Arabi; Habib Zaidi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-09-01       Impact factor: 9.236

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.